+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Authorized Generics"

From
Sunitinib Generics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Sunitinib Generics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 190 Pages
  • Global
From
Generic Pharmaceuticals Market Report 2025 - Product Thumbnail Image

Generic Pharmaceuticals Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
From
From
From
Generic Drugs Market - Product Thumbnail Image

Generic Drugs Market

  • Report
  • January 2024
  • 126 Pages
  • Global
From
From
From
From
  • 14 Results (Page 1 of 1)
Loading Indicator

Authorized generics are generic drugs that are produced and marketed by the same company that manufactures the brand-name version of the drug. This allows the company to maintain control over the production and distribution of the drug, while still providing a lower-cost alternative to the brand-name version. Authorized generics are typically priced lower than the brand-name version, but higher than other generic versions of the same drug. The authorized generics market has grown in recent years as more companies have sought to capitalize on the cost savings associated with generic drugs. This has allowed companies to increase their market share and expand their product offerings. Some of the major players in the authorized generics market include Teva Pharmaceuticals, Mylan, Sandoz, and Dr. Reddy's Laboratories. Show Less Read more